• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.

作者信息

Bock P E

机构信息

American Red Cross Blood Services, Southeastern Michigan Region, Detroit 48232.

出版信息

Biochemistry. 1988 Aug 23;27(17):6633-9. doi: 10.1021/bi00417a063.

DOI:10.1021/bi00417a063
PMID:3219359
Abstract

The feasibility of a new approach to incorporation of spectroscopic probes into the active sites of certain serine proteases has been demonstrated. The method is based on inactivation of a serine protease with a thioester derivative of a peptide chloromethyl ketone. The thiol group generated by reaction of the covalent enzyme-inhibitor complex with NH2OH provides a unique site for subsequent labeling with thiol-reactive probes. To evaluate the method, N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl was synthesized by reaction of the thrombin-specific tripeptide chloromethyl ketone with succinimidyl (acetylthio)acetate and purified by sulfopropyl-Sephadex and Sephadex G-10 chromatography. Reverse-phase high-performance liquid chromatography indicated that the product was 90 +/- 3% pure. The compound was quantitated by using 5,5'-dithiobis(2-nitrobenzoic acid) to measure the concentration of thiol produced in the presence of NH2OH. On this basis, titrations of the irreversible loss of human alpha-thrombin activity had end points of 1.1 +/- 0.1 mol of inhibitor/mol of active sites, indicating a 1:1 stoichiometry for inactivation. Incubation of N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-thrombin with 5-(iodoacetamido)fluorescein in the presence of NH2OH resulted in incorporation of 0.96 mol of the fluorescence probe/mol of active sites and the appearance of fluorescein fluorescence associated with the active site containing B-chain on sodium dodecyl sulfate-polyacrylamide gels. Fluorescence labeling of thrombin required reaction of the inhibitor at the active site as well as subsequent generation of the thiol group with NH2OH. It is concluded that active site selective labeling can be achieved by using this approach, which is likely to be applicable to other proteases, peptide chloromethyl ketones, and a wide variety of probes.

摘要

相似文献

1
Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Biochemistry. 1988 Aug 23;27(17):6633-9. doi: 10.1021/bi00417a063.
2
Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.利用硫酯肽氯甲基酮通过荧光探针进行凝血蛋白酶的活性位点选择性标记。I. 凝血酶标记的特异性
J Biol Chem. 1992 Jul 25;267(21):14963-73.
3
Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.利用硫酯肽氯甲基酮通过荧光探针进行凝血蛋白酶的活性位点选择性标记。II. 凝血酶衍生物作为凝血酶原片段2结合报告分子的性质以及该标记方法对其他蛋白酶的特异性。
J Biol Chem. 1992 Jul 25;267(21):14974-81.
4
Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.含精氨酸的肽氯甲基酮和双氯甲基酮-白蛋白缀合物对凝血酶的抑制作用。
J Enzyme Inhib. 1995;9(1):17-27. doi: 10.3109/14756369509040678.
5
Biotin derivatives of D-Phe-Pro-Arg-CH2Cl for active-site-specific labeling of thrombin and other serine proteinases.用于凝血酶及其他丝氨酸蛋白酶活性位点特异性标记的D-苯丙氨酸-脯氨酸-精氨酸-氯甲基酮的生物素衍生物
Anal Biochem. 2001 Sep 15;296(2):254-61. doi: 10.1006/abio.2001.5302.
6
Thioester peptide chloromethyl ketones: reagents for active site-selective labeling of serine proteinases with spectroscopic probes.硫酯肽氯甲基酮:用于用光谱探针进行丝氨酸蛋白酶活性位点选择性标记的试剂。
Methods Enzymol. 1993;222:478-503. doi: 10.1016/0076-6879(93)22030-j.
7
Radioiodination of the active site of tissue plasminogen activator: a method for radiolabeling serine proteases with tyrosylprolylarginyl chloromethyl ketone.
Anal Biochem. 1992 Oct;206(1):73-83. doi: 10.1016/s0003-2697(05)80013-2.
8
Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
Biochemistry. 1978 Oct 31;17(22):4778-84. doi: 10.1021/bi00615a027.
9
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.凝血酶原2、水蛭素和PPACK-凝血酶的同构结构:激活及外位点与凝血酶结合过程中的变化
Protein Sci. 1994 Dec;3(12):2254-71. doi: 10.1002/pro.5560031211.
10
Peptide chloromethyl ketones as labeling reagents.肽氯甲基酮作为标记试剂。
Methods Enzymol. 1993;222:503-13. doi: 10.1016/0076-6879(93)22031-a.

引用本文的文献

1
Allosteric inhibition of α-thrombin enzymatic activity with ultrasmall gold nanoparticles.超小金纳米颗粒对α-凝血酶酶活性的变构抑制作用。
Nanoscale Adv. 2019 Jan 1;1(1):378-388. doi: 10.1039/c8na00081f. Epub 2018 Sep 24.
2
Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparin.硫酸化低分子量木质素是通过肝素结合位点发挥作用的凝血蛋白酶变构抑制剂,与肝素相比,它能显著改变凝血酶和因子Xa的活性位点。
Thromb Res. 2014 Nov;134(5):1123-9. doi: 10.1016/j.thromres.2014.08.024. Epub 2014 Sep 6.
3
Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
结构洞察凝血辅因子 VIIIa 与因子 IXa 的相互作用:计算蛋白-蛋白对接和分子动力学精修研究。
Biochem Biophys Res Commun. 2014 Sep 26;452(3):408-14. doi: 10.1016/j.bbrc.2014.08.078. Epub 2014 Aug 23.
4
Phosphatidylserine and FVa regulate FXa structure.磷脂酰丝氨酸和 FVa 调节 FXa 结构。
Biochem J. 2014 Apr 1;459(1):229-39. doi: 10.1042/BJ20131099.
5
Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.因子 IXa 的 NH2-末端 EGF 结构域对内在凝血酶原酶特异性的贡献。
Thromb Haemost. 2012 Dec;108(6):1154-64. doi: 10.1160/TH12-06-0436. Epub 2012 Sep 26.
6
Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinase.通过组合随机和理性诱变鉴定链激酶 γ 结构域中与底物相互作用的外位点。
J Biol Chem. 2011 Feb 25;286(8):6458-69. doi: 10.1074/jbc.M110.152355. Epub 2010 Dec 17.
7
Mutagenesis studies toward understanding allostery in thrombin.旨在理解凝血酶变构作用的诱变研究。
Biochemistry. 2009 Sep 1;48(34):8261-70. doi: 10.1021/bi900921t.
8
Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex.凝血酶原酶复合物中因子Xa和凝血酶原与因子Va的膜依赖性相互作用。
Biochemistry. 2009 Jun 9;48(22):5034-41. doi: 10.1021/bi900240g.
9
Mutations in the fourth EGF-like domain affect thrombomodulin-induced changes in the active site of thrombin.第四个表皮生长因子样结构域中的突变会影响凝血酶调节蛋白诱导的凝血酶活性位点的变化。
Biochemistry. 2008 Oct 14;47(41):10933-9. doi: 10.1021/bi8008278. Epub 2008 Sep 20.
10
Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.活化蛋白C的因子X Gla结构域和凝血酶原Gla结构域嵌合体的功能特性及活性位点拓扑结构
Biochim Biophys Acta. 2008 Sep;1780(9):1080-6. doi: 10.1016/j.bbagen.2008.05.004. Epub 2008 May 19.